Humira To Compete With Remicade, Enbrel in Ankylosing Spondylitis
FDA approved Abbott’s adalimumab for reducing signs and symptoms in patients with active ankylosing spondylitis.
FDA approved Abbott’s adalimumab for reducing signs and symptoms in patients with active ankylosing spondylitis.